Experimental Activation of Endocannabinoid System Reveals Antilipotoxic Effects on Cardiac Myocytes

Molecules. 2020 Apr 21;25(8):1932. doi: 10.3390/molecules25081932.

Abstract

Hypertension coincides with myocardial alternations in lipid (including sphingolipids) and glucose metabolism. The latest data indicate that accumulation of metabolically active lipids, especially ceramide (CER) and diacylglycerol (DAG) significantly influences intracellular signaling pathways along with inducing insulin resistance. Since, it was demonstrated that the endocannabinoid system (ECS) affects myocardial metabolism it seems to be a relevant tool in alleviating metabolic disturbances within the cardiac muscle due to hypertension. All designed experiments were conducted on the animal model of primary hypertension, i.e., spontaneously hypertensive rat (SHR) with chronic ECS activation by injections of fatty acid amide hydrolase (FAAH) inhibitor-URB597. Lipid analyses were performed using chromatography techniques (gas liquid, thin layer, and high performance liquid chromatography). Colorimetric and immunoenzymatic testes were applied in order to determine plasma concentrations of insulin and glucose. Total myocardial expression of selected proteins was measured by Western blotting and/or immunohistochemistry methods. SHRs exhibited significantly intensified myocardial de novo pathway of CER synthesis as well as DAG accumulation compared to the control Wistar Kyoto rats. Besides, intramyocardial level of potentially cardioprotective sphingolipid, i.e., sphingosine-1-phosphate was considerably decreased in SHRs, whereas URB597 treatment restored the level of this derivative. Unexpectedly, ECS upregulation protected overloaded cardiac muscle against CER and DAG accumulation. Moreover, chronic URB597 treatment improved intramyocardial insulin signaling pathways in both normotensive and hypertensive conditions. It seems that the enhanced ECS triggers protective mechanisms in the heart due to decreasing the level of lipid mediators of insulin resistance.

Keywords: URB597; ceramide; diacylglycerol; glucose; insulin signaling; spontaneously hypertensive rats.

MeSH terms

  • Animals
  • Biomarkers
  • Blood Glucose / drug effects
  • Blood Pressure / drug effects
  • Endocannabinoids / pharmacology*
  • Energy Metabolism / drug effects
  • Glucose / metabolism
  • Heart Ventricles / drug effects
  • Heart Ventricles / metabolism
  • Hypertension / etiology
  • Hypertension / metabolism
  • Insulin / metabolism
  • Lipid Metabolism / drug effects*
  • Lipids / blood
  • Metabolic Networks and Pathways / drug effects
  • Myocardium / metabolism
  • Myocytes, Cardiac / drug effects*
  • Myocytes, Cardiac / metabolism*
  • Rats
  • Rats, Inbred SHR

Substances

  • Biomarkers
  • Blood Glucose
  • Endocannabinoids
  • Insulin
  • Lipids
  • Glucose